P-chloroamphetamine

P-Chloroamphetamine (PCA) is a serotonin-releasing agent (SRA) and serotonin receptor agonist that has been widely used in scientific research. It is a derivative of amphetamine, which is a powerful stimulant and psychoactive drug.

History

P-Chloroamphetamine was first synthesized in the 1950s and has been used in scientific research since the 1960s. It was initially used as a tool to deplete serotonin levels in the brain, but its use has expanded to include studies on neurotoxicity, neurodegeneration, and the role of serotonin in various psychiatric disorders.

Pharmacology

P-Chloroamphetamine acts primarily as a serotonin-releasing agent. It also acts as an agonist at the serotonin receptor, which means it can mimic the effects of serotonin in the brain. This can lead to increased mood, feelings of well-being, and increased energy levels. However, it can also lead to side effects such as anxiety, insomnia, and nausea.

Medical Use

While P-Chloroamphetamine is not used clinically, it has been used extensively in research to study the role of serotonin in the brain and its involvement in various psychiatric disorders. It has also been used to study the neurotoxic effects of amphetamines and other stimulants.

Side Effects

The side effects of P-Chloroamphetamine can include anxiety, insomnia, nausea, and increased heart rate. In addition, it can cause neurotoxicity, which can lead to long-term damage to the brain's serotonin system.

See Also

• Amphetamine
• Serotonin
• Serotonin receptor
• Neurotoxicity

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian